JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nir-Paz, R.
Right arrow Articles by Polacheck, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nir-Paz, R.
Right arrow Articles by Polacheck, I.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2003, p. 5298-5301, Vol. 41, No. 11
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.11.5298-5301.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Deep Infection by Trichophyton rubrum in an Immunocompromised Patient

Ran Nir-Paz,1,2 Hila Elinav,2 Gerald E. Pierard,3 David Walker,4 Alexander Maly,5 Mervyn Shapiro,1 Richard C. Barton,4 and Itzhack Polacheck1*

Departments of Clinical Microbiology and Infectious Diseases,1 Medicine,2 Pathology, Hadassah—Hebrew University Medical Center, Jerusalem, Israel,5 Department of Dermatopathology, University Medical Center Sart Tilman, Liège, Belgium,3 Division of Microbiology, University of Leeds and Mycology Reference Center, General Infirmary, Leeds LS2 9JT, United Kingdom4

Received 14 April 2003/ Returned for modification 26 May 2003/ Accepted 26 June 2003

Dermatophytes are common pathogens of skin but rarely cause invasive disease. We present a case of deep infection by Trichophyton rubrum in an immunocompromised patient. T. rubrum was identified by morphological characteristics and confirmed by PCR. Invasiveness was apparent by histopathology and immunohistochemistry. The patient was treated successfully with itraconazole.

* Corresponding author. Mailing address: Department of Clinical Microbiology and Infectious Diseases, Hadassah—Hebrew University Medical Center, P.O. Box 12000, Jerusalem 91120, Israel. Phone: 972-2-6776592. Fax: 972-2-6419545. E-mail: Itzhack.Polacheck{at}huji.ac.il.

Journal of Clinical Microbiology, November 2003, p. 5298-5301, Vol. 41, No. 11
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.11.5298-5301.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.